Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
CRISIL Ltd. stands out in its sector with strong profitability metrics, particularly in ROE and EPS growth, despite its higher valuation compared to peers. While Care Ratings Ltd. shows the best revenue growth, CRISIL's stable margins and no debt position it favorably against financially weaker competitors.
Highest ROE of 29.15% and strong EPS growth of 99.50%.
Highest YoY revenue growth of 21.3% and solid EBITDA margin of 46.74%.